Literature DB >> 3377270

Prevalence and prevention of deep venous thrombosis of the lower extremities in high-risk pulmonary patients.

C Ibarra-Pérez1, E Lau-Cortés, S Colmenero-Zubiate, N Arévila-Ceballos, J H Fong, R Sánchez-Martínez, M V Dominguez, J Elizalde-González.   

Abstract

Information is lacking about the prevalence of, and the best method of preventing deep venous thrombosis (DVT) of the lower extremities in patients forty years or older with pulmonary disease that keeps them in bed for three consecutive days or more and who are thus at high risk of developing DVT or pulmonary embolism (PE). In this study, 192 high-risk patients, aged forty to ninety-two, received 125I fibrinogen and had daily radioactive scans, venous Doppler, and strain gauge plethysmography. Four preventive methods were used until patients became ambulatory: graded compression stockings (GCS) in 39, elastic bandages (EB) in 33, subcutaneous administration of 5,000 USP units of heparin (HEP) bid in 39, and oral administration of 0.5 g of acetylsalicyclic acid (ASA) bid in 35. Results were compared with those in 46 patients in a control group (CG). Twelve patients in CG, none in GCS, 4 in EB, 1 in HEP, and 2 in ASA developed DVT proved by contrast venography. There was a statistically significant difference between GCS and CG (P less than 0.0003), HEP and CG (P less than 0.0022), and ASA and CG (P less than 0.0148) but not between EB and CG (P greater than 0.10); no significant differences were found between any pair of prophylaxis groups. The significant differences could not be attributed to differences in age, sex, or length of stay in bed. PE occurred in 3 patients in CG and 1 in EB. Hemorrhagic complications occurred in 7 patients in HEP and 4 in ASA, requiring exclusion of 2 patients and 1 patient, respectively, from the study.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1988        PMID: 3377270     DOI: 10.1177/000331978803900603

Source DB:  PubMed          Journal:  Angiology        ISSN: 0003-3197            Impact factor:   3.619


  9 in total

Review 1.  Risk-assessment algorithm and recommendations for venous thromboembolism prophylaxis in medical patients.

Authors:  Ana T Rocha; Edison F Paiva; Arnaldo Lichtenstein; Rodolfo Milani; Cyrillo Filho Cavalheiro; Francisco H Maffei
Journal:  Vasc Health Risk Manag       Date:  2007

2.  Implementation and evaluation of a pharmacy-led thromboprophylaxis campaign in a community hospital.

Authors:  Marie-Christine Bernier; Karine Desjardins; Josée Filiatrault; Marc-André Sauriol; Josée Martineau; Edith Gilbert; Stéphanie Caron; Lyne Lalonde
Journal:  J Thromb Thrombolysis       Date:  2011-11       Impact factor: 2.300

3.  Management and prevention of venous thromboembolism including surgery and the pregnant state.

Authors:  Steven B Deitelzweig
Journal:  Ochsner J       Date:  2002

Review 4.  Effect of thromboprophylaxis with anticoagulant drugs on the incidence of arterial thrombotic events in medical inpatients: a systematic review.

Authors:  Alessandro Squizzato; Federico Lussana; Walter Ageno; Marco Cattaneo
Journal:  Intern Emerg Med       Date:  2016-03-15       Impact factor: 3.397

Review 5.  Deep venous thrombosis prophylaxis in patients with heart disease.

Authors:  B K Shively
Journal:  Curr Cardiol Rep       Date:  2001-01       Impact factor: 2.931

6.  American Society of Hematology 2018 guidelines for management of venous thromboembolism: prophylaxis for hospitalized and nonhospitalized medical patients.

Authors:  Holger J Schünemann; Mary Cushman; Allison E Burnett; Susan R Kahn; Jan Beyer-Westendorf; Frederick A Spencer; Suely M Rezende; Neil A Zakai; Kenneth A Bauer; Francesco Dentali; Jill Lansing; Sara Balduzzi; Andrea Darzi; Gian Paolo Morgano; Ignacio Neumann; Robby Nieuwlaat; Juan J Yepes-Nuñez; Yuan Zhang; Wojtek Wiercioch
Journal:  Blood Adv       Date:  2018-11-27

7.  An update on prevention of venous thromboembolism in hospitalized acutely ill medical patients.

Authors:  Meyer Michel Samama; Franz-Xaver Kleber
Journal:  Thromb J       Date:  2006-07-03

Review 8.  Heparin for the prevention of venous thromboembolism in acutely ill medical patients (excluding stroke and myocardial infarction).

Authors:  Raza Alikhan; Rachel Bedenis; Alexander T Cohen
Journal:  Cochrane Database Syst Rev       Date:  2014-05-07

Review 9.  Primary prevention of venous thromboembolism in elderly medical patients.

Authors:  Karine Lacut; Gregoire Le Gal; Dominique Mottier
Journal:  Clin Interv Aging       Date:  2008       Impact factor: 4.458

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.